GUSB, glucuronidase beta, 2990

N. diseases: 183; N. variants: 41
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.010 GeneticVariation disease BEFREE We found markers of chronic alcohol consumption (HEX A), alcohol dependence (FUC and MAN) and chronic alcohol consumption and dependence (GLU). 28660791 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 Biomarker disease BEFREE A screen of genes encoding B-GUS and GDH was performed for fecal microbiome data from healthy individuals (n = 103) and from CRC patients (n = 53), which revealed a decrease in abundance of taxa with confirmed GDH and HCA transformation activity in CRC patients. 31096909 2019
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 AlteredExpression disease BEFREE In the course of diabetes and insulin resistance, an intensified defensive activity of cells against the oxidative stress was observed in the undamaged skin, expressed by an increase in the relative content of superoxide dismutase 2 and 3, catalase and the activity of N-acetyl-β-d-hexosaminidase and β-d-glucuronidase. 31146169 2019
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.010 Biomarker group BEFREE Bacterial β-glucuronidase alleviates dextran sulfate sodium-induced colitis in mice: A possible crucial new diagnostic and therapeutic target for inflammatory bowel disease. 30967260 2019
CUI: C0028259
Disease: Nodule
Nodule
0.010 AlteredExpression phenotype BEFREE Promoter::β-glucuronidase fusion showed that the promoter activity was localized in the root infection/differentiation zone during the early stage of rhizobial infection and in the vascular bundle of the mature nodule. 30976084 2019
CUI: C0029166
Disease: Oral Manifestations
Oral Manifestations
0.010 GeneticVariation phenotype BEFREE Oral manifestations in patients affected with MPS VII have never been reported. 30653816 2019
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.010 AlteredExpression disease BEFREE The three algorithms were in agreement in identifying GUSB and HPRT1 as the most stably expressed genes in all thyroid tumors investigated. 31645594 2019
CUI: C0040149
Disease: Subacute thyroiditis
Subacute thyroiditis
0.010 AlteredExpression disease BEFREE ROC curve analysis revealed that β-G activity had a high predictive value for destructive processes, namely AIT2 and subacute thyroiditis (AUC 0.846, 95% CI 0.748-0.943) and a cut-off value of 1,480.5 nmol 4-MU/mL plasma/h was able to discriminate between destructive and non-destructive thyroid conditions with 74% sensitivity and 82% specificity. 31602365 2019
CUI: C0151846
Disease: Periosteal Disorder
Periosteal Disorder
0.010 Biomarker disease BEFREE The markers of inflammation [interleukin 1 (IL-1), interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β) and β-glucuronidase (GLU)] as well as apoptosis [Bax, Bax/Bcl-2 ratio, caspase-3 (CAS-3) and nitric oxide (NO)] were significantly elevated in periosteum covering titanium fixations compared to the control group. 31781128 2019
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.010 AlteredExpression disease BEFREE The beta-glucuronidase (GUS) activity driven by the promoter of <i>GmTIP2;6</i> was strongly induced in the heat- and ACC-treated transgenic plants and tended to be accumulated in the hypocotyls, vascular bundles, and leaf trichomes. 30634702 2019
CUI: C0231341
Disease: Premature aging syndrome
Premature aging syndrome
0.010 GeneticVariation disease BEFREE Mutations of the β-glucuronidase protein α-Klotho have been associated with premature aging, and altered cognitive function. 29493420 2019
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.010 Biomarker disease BEFREE These results suggest that GUSB and HPRT1 are promising reference genes for normalization of relative qRT-PCR studies in papillary thyroid carcinoma. 31645594 2019
CUI: C0266062
Disease: Posterior open bite
Posterior open bite
0.010 Biomarker phenotype BEFREE Dogs affected with MPS VII had anterior and posterior open bite, maxillary hypoplasia, premolar crowding, and mandibular prognathism. 30653816 2019
CUI: C0282160
Disease: Aplasia Cutis Congenita
Aplasia Cutis Congenita
0.010 AlteredExpression disease BEFREE The beta-glucuronidase (GUS) activity driven by the promoter of <i>GmTIP2;6</i> was strongly induced in the heat- and ACC-treated transgenic plants and tended to be accumulated in the hypocotyls, vascular bundles, and leaf trichomes. 30634702 2019
Hyperthyroidism secondary to amiodarone
0.010 GeneticVariation disease BEFREE Plasma Beta-Glucuronidase Activity: A Novel Tool to Distinguish Type 1 from Type 2 Amiodarone-Induced Thyrotoxicosis? 31602365 2019
CUI: C0345392
Disease: Congenital kyphoscoliosis
Congenital kyphoscoliosis
0.010 Biomarker disease BEFREE Patients with MPS VII exhibit progressive skeletal deformity including kyphoscoliosis and joint dysplasia, which decrease quality of life and increase mortality. 31442675 2019
CUI: C0376154
Disease: Skin callus
Skin callus
0.010 AlteredExpression disease BEFREE The system is tightly regulated and highly sensitive to DEX application, with 6 h of induction sufficient to induce high levels of GUS activity in transgenic callus. 31615413 2019
CUI: C0399526
Disease: Class III malocclusion
Class III malocclusion
0.010 Biomarker disease BEFREE Dogs affected with MPS VII had anterior and posterior open bite, maxillary hypoplasia, premolar crowding, and mandibular prognathism. 30653816 2019
CUI: C0575158
Disease: Kyphoscoliosis deformity of spine
Kyphoscoliosis deformity of spine
0.010 Biomarker disease BEFREE Patients with MPS VII exhibit progressive skeletal deformity including kyphoscoliosis and joint dysplasia, which decrease quality of life and increase mortality. 31442675 2019
CUI: C0600033
Disease: Acquired Kyphoscoliosis
Acquired Kyphoscoliosis
0.010 Biomarker disease BEFREE Patients with MPS VII exhibit progressive skeletal deformity including kyphoscoliosis and joint dysplasia, which decrease quality of life and increase mortality. 31442675 2019
CUI: C0010068
Disease: Coronary heart disease
Coronary heart disease
0.010 Biomarker disease BEFREE We have implicated mutations in GATA3, KCNH2, ENG, FLNA, and GUSB genes as an underlying risk factor for CHD in DS patients. 30105468 2018
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.010 Biomarker group BEFREE It has been successfully used to detect and image endogenous GLU in various hepatoma carcinoma cells, tumor tissues, and tumor-bearing mouse models, for cancer diagnosis and therapy. 29400050 2018
CUI: C0241210
Disease: Speech Delay
Speech Delay
0.010 Biomarker disease BEFREE Most patients with MPS VII have intellectual disability and severely delayed speech development, usually associated with hearing impairment. 30442188 2018
CUI: C0242510
Disease: Drug usage
Drug usage
0.010 GeneticVariation phenotype BEFREE It could also evaluate real intestinal distribution and real-time variations of GLU in development and growth, all of which are very helpful to guide rational drug use in the clinic. 29400050 2018
CUI: C0574143
Disease: Liver calculus
Liver calculus
0.010 Biomarker disease BEFREE Our clinical observations and experimental data indicate that LPS could induce the increased expression and secretion of endogenous β-glucuronidase via a signaling cascade of PKC/NF-κB/c-myc in hepatocytes and intrahepatic biliary epithelial cells, and endogenous β-glucuronidase might play a possible role in the formation of hepatolithiasis. 29188532 2018